Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun;50(6):849-860.
doi: 10.1007/s00134-024-07454-z. Epub 2024 May 15.

Management of hematological patients requiring emergency chemotherapy in the intensive care unit

Collaborators, Affiliations
Review

Management of hematological patients requiring emergency chemotherapy in the intensive care unit

Antoine Lafarge et al. Intensive Care Med. 2024 Jun.

Erratum in

Abstract

Hematological malignancies may require rapid-onset treatment because of their short doubling time, notably observed in acute leukemias and specific high-grade lymphomas. Furthermore, in targeted onco-hematological scenarios, chemotherapy is deemed necessary as an emergency measure when facing short-term, life-threatening complications associated with highly chemosensitive hematological malignancies. The risks inherent in the disease itself, or in the initiation of treatment, may then require admission to the intensive care unit (ICU) to optimize monitoring and initial management protocols. Hyperleukocytosis and leukostasis in acute leukemias, tumor lysis syndrome, and disseminated intravascular coagulation are the most frequent onco-hematological complications requiring the implementation of emergency chemotherapy in the ICU. Chemotherapy must also be started urgently in secondary hemophagocytic lymphohistiocytosis. Tumor-induced microangiopathic hemolytic anemia and plasma hyperviscosity due to malignant monoclonal gammopathy represent infrequent yet substantial indications for emergency chemotherapy. In all cases, the administration of emergency chemotherapy in the ICU requires close collaboration between intensivists and hematology specialists. In this review, we provide valuable insights that aid in the identification and treatment of patients requiring emergency chemotherapy in the ICU, offering diagnostic tools and guidance for their overall initial management.

Keywords: Acute leukemia; Chemotherapy; Emergency; ICU; Lymphoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interests.

Figures

Fig. 1
Fig. 1
Inaugural complications of acute myeloid leukemia requiring emergency chemotherapy. A Pulmonary leukostasis, with bilateral alveolar and interstitial opacities, related to hyperleukocytic (230 × 109/L) acute monocytic leukemia (ex FAB-M5) at the time of diagnosis. B Pulmonary leukostasis, with ground-glass opacity in the right upper lobe, secondary to hyperleukocytic (200 × 109/L) acute myelomonocytic leukemia (ex FAB-M4). C Fundus image with fluorescein angiography revealing hyperviscosity-related retinopathy with disseminated retinal hemorrhages and vascular dilation. D, E T2*-weighted and T2-flair MRI sequences revealing inaugural left fronto-temporal hemorrhage and cerebral edema linked to hyperleukocytic (330 × 109/L) acute monocytic leukemia (ex FAB-M5). F Acute monocytic leukemia (ex FAB-M5): peripheral blood smear with numerous promonocytes that have folded and convoluted nuclei and a finely granulated cytoplasm and vacuoles. DIC disseminated intravascular coagulation, FAB French–American–British classification, MRI magnetic resonance imaging

References

    1. Wohlfarth P, Staudinger T, Sperr WR, Bojic A, Robak O, Hermann A, Laczika K, Carlstrom A, Riss K, Rabitsch W, Bojic M, Knoebl P, Locker GJ, Obiditsch M, Fuhrmann V, Schellongowski P, Arbeitsgruppe fur hamato-onkologische Intensivmedizin der Osterreichischen Gesellschaft fur Internistische und Allgemeine Intensivmedizin und N Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit. Ann Hematol. 2014;93:1629–1636. - PubMed
    1. Benoit DD, Depuydt PO, Vandewoude KH, Offner FC, Boterberg T, De Cock CA, Noens LA, Janssens AM, Decruyenaere JM. Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit. Intensive Care Med. 2006;32:93–99. - PubMed
    1. Song JU, Suh GY, Chung MP, Kim H, Kwon OJ, Jung CW, Kang WK, Park K, Jeon K. Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit. Support Care Cancer. 2011;19:491–495. - PubMed
    1. Moors I, Pene F, Lengline E, Benoit D. Urgent chemotherapy in hematological patients in the ICU. Curr Opin Crit Care. 2015;21:559–568. - PubMed
    1. Vandijck DM, Benoit DD, Depuydt PO, Offner FC, Blot SI, Van Tilborgh AK, Nollet J, Steel E, Noens LA, Decruyenaere JM. Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med. 2008;34:847–855. - PubMed

MeSH terms

Substances

LinkOut - more resources